Safety of Drug-Eluting Stents in Patients With Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 102, Issue 6, 2008, Pages 679-682

  Nusca, Annunziata ^a,b   Lipinski, Michael J ^c   Varma, Amit ^a   Appleton, Darryn L ^a   Goudreau, Evelyne ^a   Cowley, Michael J ^a   Wittkamp, Michael J ^a   Di Sciascio, Germano ^b   Vetrovec, George W ^a   Abbate, Antonio ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 50949105359     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.049     Document Type: Article

References (14)

1. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
2. Moussa I., Di Mario C., Reimers B., Akiyama T., Tobis J., and Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 29 (1997) 6-12
3. Win H.K., Caldera A.E., Maresh K., Lopez J., Rihal C.S., Parikh M.A., Granada J.F., Marulkar S., Nassif D., Cohen D.J., Kleiman N.S., and EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
4. Lipinski M.J., Martin R.E., Cowley M.J., Goudreau E., Malloy W.N., and Vetrovec G.W. Improved survival for stenting vs. balloon angioplasty for the treatment of coronary artery disease in patients with ischemic left ventricular dysfunction. Catheter Cardiovasc Interv 66 (2005) 547-553
5. Di Sciascio G., Patti G., D'Ambrosio A., and Nusca A. Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population. Catheter Cardiovasc Interv 59 (2003) 429-433
6. Biondi-Zoccai G.G.L., Moretti C., Abbate A., Lipinski M.J., De Luca G., Agostoni P., Meliga E., Goudreau E., Vetrovec G.W., Trevi G.P., and Sheiban I. Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. EuroInterv 3 (2007) 409-415
7. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
8. Applegate R.J., Sacrinty M.T., Kutcher M.A., Santos R.M., Gandhi S.K., Baki T.T., and Little W.C. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 51 (2008) 607-614
9. Marroquin O.C., Selzer F., Mulukutla S.R., Williams D.O., Vlachos H.A., Wilensky R.L., Tanguay J.F., Holper E.M., Abbott J.D., Lee J.S., et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358 (2008) 342-352
10. Gioia G., Matthai W., Benassi A., Rana H., Levite H.A., and Ewing L.G. Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction. Catheter Cardiovasc Interv 68 (2006) 392-398
11. Walters D.L., Harding S.A., Walsh C.R., Wong P., Pomerantsev E., and Jang I.K. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol 89 (2002) 491-494
12. Chen M.S., John J.M., Chew D.P., Lee D.S., Ellis S.G., and Bhatt D.L. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 (2006) 1260-1264
13. Bossi I., Klersy C., Black A.J., Cortina R., Choussat R., Cassagneau B., Jordan C., Laborde J.C., Laurent J.P., Bernies M., Fajadet J., and Marco J. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 35 (2000) 1569-1576
14. Assali A.R., Moustapha A., Sdringola S., Denktas A.E., Willerson J.T., Holmes Jr. D.R., and Smalling R.W. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol 98 (2006) 729-733